A perspective on the widening gap between Covishield vaccine doses in India
DOI:
https://doi.org/10.47203/IJCH.2021.v33i03.026Keywords:
Covishield, Serum Institute of India, Vaccine ShortageAbstract
The Oxford University-AstraZeneca’s vector-based vaccine called Covishield (ChAdOx1 nCoV- 19 Vaccine) is being manufactured and distributed by Serum Institute of India (SII). National roll out of this vaccine was in a phased manner starting from 16th January 2021. At present, many states are facing shortage of vaccines. Government of India kept changing its policy on dosing gap of Covishield vaccine based on researches. The latest recommendation citing “real-life evidence” from the UK is to extend the two doses of Covishield to 12-16 weeks. This reasonable approach will not only a breathing space for the government but also aids in free up doses for a larger number of people to get their first dose of the vaccine.
Downloads
References
Serum Institute of India. FACT SHEET FOR VACCINE RECIPIENT [Internet]. 2021 [cited 2021 May 14]. Available from: https://www.seruminstitute.com/pdf/covishield_fact_sheet.pdf
Covid-19 vaccination in India Day 1: Over 1.9 lakh people inoculated, says govt [Internet]. mint. 2021 [cited 2021 May 14]. Available from: https://www.livemint.com/news/india/covid19-vaccination-in-india-day-1-over-1-6-lakh-people-inoculated-3-351-sessions-held-says-govt-11610804057599.html
Shampa sen. DNA Explainer: What happens if you take one shot of Covaxin and the other of Covishield? DNA Web team [Internet]. 2021[cited 2021 Jul 23]; Available from: https://www.dnaindia.com/explainer/report-dna-explainer-what-happens-if-you-take-one-shot-of-covaxin-and-the-other-of-covishield-2890449
Extended gap between 2 doses of Covishield reasonable approach: Anthony Fauci [Internet]. mint. 2021 [cited 2021 May 14]. Available from: https://www.livemint.com/news/india/extended-gap-between-2-doses-of-covishield-reasonable-approach-anthony-fauci-11620956469530.html
Covishield 90% effective if doses given after gap of 2-3 months: Adar Poonawalla [Internet]. [cited 2021 May 14]. Available from: https://www.businesstoday.in/coronavirus/covishield-90-effective-if-doses-given-after-gap-of-2-3-months-adar-poonawalla/story/435843.html
Explained: When to take your vaccine shot(s) if infected with Covid-19, and if not [Internet]. The Indian Express. 2021 [cited 2021 May 14]. Available from: https://indianexpress.com/article/explained/explained-when-to-take-your-jabs-if-infected-and-if-not-7312737/
Singh AK, Phatak SR, Singh NK, Gupta A, Sharma A, Bhattacharjee K, et al. Antibody Response after First-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) amongst Health Care Workers in India: Preliminary Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study. medRxiv [Internet]. [cited 2021 May 14]; Available from: https://www.medrxiv.org/content/early/2021/04/13/2021.04.07.21255078
Explainer: Will Extending Gap Between Two Covishield Doses Help Save More People? [Internet]. Moneycontrol. [cited 2021 May 14]. Available from: https://www.moneycontrol.com/news/business/companies/explainer-will-extending-gap-between-two-covishield-doses-help-save-more-people-6890351.html
ITWDN, 2021 UPDATED. Oxford vaccine 90% effective if doses given 2-3 months apart: Adar Poonawalla [Internet]. India Today. [cited 2021 May 14]. Available from: https://www.indiatoday.in/coronavirus-outbreak/story/covishield-oxford-covid-vaccine-90-effective-2-3-months-apart-serum-institute-adar-poonawalla-1787597-2021-04-06
Manavi Kapur. India’s lofty vaccination goal rests on supplies that may or may not turn up. [Internet]. Quartz India.2021 [cited 2021 Jul 23]; Available from: https://qz.com/india/2013630/will-india-have-enough-covaxin-and-covishield-doses-by-december/
Hung IFN, Poland GA. Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster. The Lancet. 2021;397(10277):854–5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Indian Journal of Community Health
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
